4.79

0.83% -0.04

Optimi Health Corp (OPTH)

Overview News Price History Discussions Forecast

Optimi Health Corp stock is traded at $4.79, with a volume of 23,218. It is down -0.83% in the last 24 hours and up +16.55% over the past month. Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

Previous Close:

$4.83

Open:

$4.66

24h Volume:

23,218

Relative Volume:

0.23

Market Cap:

$27.43M

Revenue:

$257.00K

Net Income/Loss:

$-3.07M

P/E Ratio:

-5.0278

EPS:

-0.9527

Net Cash Flow:

$-1.40M

1W Performance:

-5.15%

1M Performance:

+16.55%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.66

$4.82

1-Week Range:

$4.51

$5.15

52-Week Range:

$4.00

$6.20

Optimi Health Corp Stock (OPTH) Company Profile

Name

Optimi Health Corp

Sector

Healthcare (1080)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-09-07

Latest SEC Filings

OPTH's Discussions on Twitter

Compare OPTH vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPTH Optimi Health Corp	4.79	27.20M	257.00K	-3.07M	-1.40M	-0.9527
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Optimi Health Corp Stock (OPTH) Latest News

Aug 14, 2026

Top Optimi Health (OPTH) Competitors 2026 - MarketBeat

Aug 14, 2026

Optimi Health (OPTH) Stock Chart and Price History 2026 - MarketBeat

Aug 14, 2026

Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks

Aug 14, 2026

Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan

Aug 14, 2026

Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca

Aug 14, 2026

Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan

Aug 14, 2026

Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative

Aug 14, 2026

Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance

Aug 14, 2026

Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - Kalkine

Aug 14, 2026

Aug 13, 2026

SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits

Aug 13, 2026

Aug 12, 2026

Optimi Health Stock Slides 3.4% on August 11 — Is This Psychedelics Manufacturer Getting Interesting Again? - kalkine.ca

Aug 12, 2026

Aug 10, 2026

Optimi Health Corp (CN:OPTI) Shares Under Pressure as Psychedelic Market Uncertainty and Development Risks Weigh on Sentiment - kalkine.ca

Aug 10, 2026

Aug 07, 2026